Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001667699-22-000002
Filing Date
2022-07-29
Accepted
2022-07-29 16:52:33
Documents
1
Effectiveness Date
2022-07-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10190
  Complete submission text file 0001667699-22-000002.txt   11262
Mailing Address 950 E. STATE HIGHWAY 114 STE-160 SOUTHLAKE TX 76092
Business Address 950 E. STATE HIGHWAY 114 STE-160 SOUTHLAKE TX 76092 386-527-1071
Renibus Therapeutics, Inc. (Filer) CIK: 0001667699 (see all company filings)

EIN.: 810872431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-454246 | Film No.: 221121588